The NIH awarded GlobalStem two phase 1 SBIR grants. Under the first grant, the company will affiliate with a trans-NIH initiative called the Knockout Mouse Project (KOMP) to make mouse embryonic stem cell lines available for research. The second grant will help GlobalStem create genetically modified human feeder cells for the support of undifferentiated hESC.
GlobalStem will work with NIH and other federal agencies to provide the international stem cell community with products that allow customers to conduct research with greater speed, efficiency, and confidence, notes Jonathan M. Auerbach, Ph.D., president.
GlobalStem develops, manufactures, and distributes human and mouse stem cell research products and services. The company currently sells products in four categories: cells, media, sera, and supporting products and tools. In addition, it offers cell characterization services.